This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Desai Neil | 1,915,543 | 0 |
| Satter Muneer A | 374,789 | 0 |
| Khuong Chau Quang | 346,263 | 0 |
| Novartis Bioventures Ltd | 269,986 | 0 |
| WEISS PAUL M | 105,077 | 0 |
| Dalal Anupam | 101,960 | 0 |
| Gardner Joseph H. | 30,201 | 0 |
| PETERS KEVIN G. | 21,369 | 0 |
| Castelein Caley | 17,333 | 0 |
| HOFFMAN STEPHEN J | 2,131 | 0 |
| ITRI LORETTTA M By spouse | 0 | 0 |
| Aghazadeh Behzad | 0 | 0 |
| ORBIMED ADVISORS LLC | 0 | 0 |
| Dugel Pravin | 0 | 0 |
| Marek Regina | 0 | 0 |
| Reeve Emma | 0 | 0 |
| Avoro Ventures LLC | 0 | 0 |
| Prelack Steven | 0 | 0 |
| ROGERS MICHAEL W | 0 | 0 |
| PAKOLA STEVE | 0 | 0 |
| DESAI DHAVAL | 0 | 0 |
| ISALY SAMUEL D | 0 | 0 |
| NOVARTIS AG | 0 | 0 |
| 0 | 0 | |
| Delaney Brendan | 0 | 0 |
| Cohen Cheryl | 0 | 0 |
| Giacobello Scott M. | 0 | 0 |
| ITRI LORETTTA M | 0 | 0 |
| Hehenberger Karin M. | 0 | 0 |
| Maroun Richard E | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|---|---|---|
| Desai Neil | 3,550 | 20.07 | 2022 Mar 18 |
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|